Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for InnovAge Holding Corp. (INNV : NSDQ)
 
 • Company Description   
InnovAge Holding Corp. is a healthcare delivery platform. The Company delivers its patient-centered care through the InnovAge Platform. InnovAge Platform is focused on frail, dual-eligible seniors as well as it serve participants primarily through Program of All-inclusive Care for the Elderly. InnovAge Holding Corp. is based in DENVER, United States.

Number of Employees: 2,440

 
 • Price / Volume Information   
Yesterday's Closing Price: $7.20 Daily Weekly Monthly
20 Day Moving Average: 276,124 shares
Shares Outstanding: 135.74 (millions)
Market Capitalization: $977.30 (millions)
Beta: 0.49
52 Week High: $10.69
52 Week Low: $3.13
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -6.98% -11.52%
12 Week -22.58% -28.43%
Year To Date 38.73% 30.56%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
8950 E. LOWRY BOULEVARD
-
DENVER,CO 80230
USA
ph: 844-803-8745
fax: -
rkubota@innovage.com http://www.innovage.com
 
 • General Corporate Information   
Officers
Patrick Blair - Chief Executive Officer
James Carlson - Chairman of the Board
Benjamin C. Adams - Chief Financial Officer
John Ellis Bush - Director
Andrew Cavanna - Director

Peer Information
InnovAge Holding Corp. (CHCR)
InnovAge Holding Corp. (ESRX)
InnovAge Holding Corp. (MYDP)
InnovAge Holding Corp. (COR)
InnovAge Holding Corp. (GBCS)
InnovAge Holding Corp. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 45784A104
SIC: 8000
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 09/08/26
Share - Related Items
Shares Outstanding: 135.74
Most Recent Split Date: (:1)
Beta: 0.49
Market Capitalization: $977.30 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.06 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.17 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 09/08/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 42.35
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.20
Price/Cash Flow: -
Price / Sales: 1.03
EPS Growth
vs. Year Ago Period: -175.00%
vs. Previous Quarter: -375.00%
Sales Growth
vs. Year Ago Period: 15.49%
vs. Previous Quarter: 5.10%
ROE
03/31/26 - -4.73
12/31/25 - 2.60
09/30/25 - -7.02
ROA
03/31/26 - -2.20
12/31/25 - 1.23
09/30/25 - -3.31
Current Ratio
03/31/26 - 1.03
12/31/25 - 1.26
09/30/25 - 1.17
Quick Ratio
03/31/26 - 1.03
12/31/25 - 1.26
09/30/25 - 1.17
Operating Margin
03/31/26 - -1.22
12/31/25 - 0.71
09/30/25 - -1.96
Net Margin
03/31/26 - -1.22
12/31/25 - 0.71
09/30/25 - -1.96
Pre-Tax Margin
03/31/26 - -1.43
12/31/25 - 0.56
09/30/25 - -2.35
Book Value
03/31/26 - 1.71
12/31/25 - 1.92
09/30/25 - 1.84
Inventory Turnover
03/31/26 - -
12/31/25 - -
09/30/25 - -
Debt-to-Equity
03/31/26 - 0.26
12/31/25 - 0.24
09/30/25 - 0.25
Debt-to-Capital
03/31/26 - 27.20
12/31/25 - 25.42
09/30/25 - 26.14
 

Powered by Zacks Investment Research ©